Sena BF, Herrera BB, Martina DGB, Filho JLL. Geospatial clustering reveals dengue hotspots across Brazilian municipalities, 2024. Frontiers in Public Health. 2025
Alatrash R & Herrera BB. Immunodominant structural proteins Gc and N drive T cell-mediated protection against La Crosse virus. iScience. 2025.
Tonto PB, Gallon S, Alatrash R, Ding Y, Wang WK & Herrera BB. Pre-existing YFV-17D immunity mediates T cell cross-protection against dengue virus serotype 2 infection in mice. Communications Biology. 2025.
Kim TW, Herrera BB, Chaplin B, Keoho KN, Ogwuche J, Sagay AS, Chang CA, Wang WK, Kanki PJ. Preexisting yellow fever virus and West Nile virus immunity and pregnancy outcomes in a Nigerian cohort with endemic Orthoflavivirus exposure. Emerging Microbes and Infection. 2025.
Lumkong L, Alatrash R, Sridhar S, Tonto PB, Herrera BB. Development of an RT-RPA assay for La Crosse virus detection provides insights into age-dependent neuroinvasion in mice. Virology Journal. 2025.
Gallon S, Tonto PB, Sy M, Ndiaye IM, Toure M, Gaye A, Aidara M, Mbaye AM, Dia AK, Diallo MA, Gomis JF, Yade MS, Diedhiou Y, Dieye B, Diongue K, Seck MC, Badiane AS, Ndiaye D, Herrera BB. Seropositivity to dengue, Zika, yellow fever, and West Nile viruses in Senegal, West Africa. Journal of Medical Virology. 2025.
Tonto PB, Sy M, Ndiaye IM, Toure M, Gaye A, Aidara M, Mbaye AM, Dia AK, Diallo MA, Gomis JF, Yade MS, Diedhiou Y, Dieye B, Diongue K, Seck MC, Badiane AS, Herrera BB, Ndiaye D. Seroprevalence of Chikungunya and O'nyong-nyong Viruses in Senegal, West Africa. Journal of Medical Virology. 2025.
Brites C, Baffour Tonto P, Vallinoto AC, dos Santos Oliveira O, Simionatto S, Bay M, Reuter T, Gomes M, Medeiros M, Mayoral R, Luz E, Herrera BB. Multicenter cross-sectional study of HTLV-1 prevalence and associated risk factors in epidemiologically relevant groups across Brazil. Frontiers in Public Health. 2025.
Herrera BB, Chaplin B, MBoup S, Abdullahi A, He M, Fisher SM, Akanmu S, Chang CA, Hamel DJ, Gupta RK, Kanki PJ. Pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2 among female sex workers in Dakar, Senegal. Frontiers in Public Health. 2025.
Sainetra S, Baffour Tonto P, Lumkong L, Netto EM, Brites C, Wang WK, Herrera BB. RT-RPA as a dual tool for detectionand phylogenetic analysis ofepidemic arthritogenic alphaviruses. Scientific Reports. 2024 14:30134.
Alatrash R, Vaidya V & Herrera BB. Age-specific dynamics of neutralizing antibodies, cytokines, and chemokines in response to La Crosse virus infection in mice. Journal of Virology. 2024 Nov 5:e01762-24.
Joseph J, Premeaux TA, Tandon R, Murphy EL, Bruhn R, Nicot C, Herrera BB, Lemenze A, Alatrash R, Tonto PB, Ndhlovu LC, & Jain P. Dendritic Cells Pulsed with HAM/TSP Exosomes Sensitize CD4 T Cells to Enhance HTLV-1 Infection, Induce Helper T-Cell Polarization, and Decrease Cytotoxic T-Cell Response. 2024, 16, 1443.
Alatrash R, Herrera BB. The Adaptive Immune Response against Bunyavirales. Viruses. 2024 Mar 21;16(3):483.
Joseph J, Sandel G, Kulkarni R, Alatrash R, Herrera BB, Jain P. Antibody and Cell-based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. Pathogens. 2023. 10.3390/pathogens13010014.
Akanmu S, Herrera BB, Chaplin B, Ogunsola S, Osibogun A, Onawoga F, John-Olabode S, Akase IE, Nwosu A, Hamel DJ, Chang CA. High SARS-CoV-2 seroprevalence in Lagos, Nigeria with Robust Antibody and Cellular Immune Responses. Journal of Clinical Virology Plus. 2023 Jun 24:100156.
Herrera BB, Mayoral R, Brites C. Development and Validation of a Rapid Screening Test for HTLV-I IgG Antibodies. Viruses. 2023 Jan;15(1):129.
Salcedo N, Reddy A, Gomez AR, Bosch I, Herrera BB. Monoclonal antibody pairs against SARS-CoV-2 for rapid antigen test development. PLoS neglected tropical diseases. 2022 Mar 31;16(3):e0010311.
Salcedo N, Sena BF, Qu X, Herrera BB. Comparative evaluation of rapid isothermal amplification and antigen assays for screening testing of SARS-CoV-2. Viruses. 2022 Feb 25;14(3):468.
Nash B, Badea A, Reddy A, Bosch M, Salcedo N, Gomez AR, Versiani A, Silva GC, dos Santos TM, Milhim BH, Moraes MM, Campos GRF, Quieroz F, Reis AFN, Noguiera ML, Naumova EN, Bosch I, Herrera BB. Validating and modeling the impact of high-frequency rapid antigen screening on COVID-19 spread and outcomes. Journal of Clinical Trials. 2021 Oct 11:11:483.
Salcedo N, Harmon A, Herrera BB. Pooling of Samples for SARS-CoV-2 Detection Using a Rapid Antigen Test. Frontiers in Tropical Diseases. 2021;2.
Harmon A, Chang C, Salcedo N, Sena B, Herrera BB, Bosch I, Holberger LE. Validation of an at-home direct antigen rapid test for COVID-19. JAMA network open. 2021 Aug 2;4(8):e2126931-.
Reddy A, Bosch I, Salcedo N, Herrera BB, de Puig H, Narváez CF, Caicedo-Borrero DM, Lorenzana I, Parham L, García K, Mercado M, Turca AMR, Villar-Centeno LA, Galvez-Ramirez M, Rios NAG, Hiley M, Garcia D, Diamond MS, Lee Gehrke. Development and validation of a rapid lateral flow E1/E2-antigen test and ELISA in patients infected with emerging Asian strain of Chikungunya virus in the Americas. Viruses. 2020 Sep 1;12(9):971.
Bosch I, Reddy A, de Puig H, Ludert JE, Perdomo-Celis F, Narváez CF, Versiani A, Fandos D, Nogueira ML, Singla M, Lodha R, Medigeshi GR, Lorenzana I, Raide HV, Gelvez-Ramirez M, Villar LA, Hiley M, Mendoza L, Salcedo N, Herrera BB, Lee G. Serotype-specific detection of dengue viruses in a nonstructural protein 1-based enzyme-linked immunosorbent assay validated with a multi-national cohort. PLoS neglected tropical diseases. 2020 Jun 24;14(6):e0008203.
Vasey B, Shankar AH, Herrera BB, Becerra A, Xhaja K, Echenagucia M, Machado SR, Caicedo D, Miller J, Amedeo P, Naumova EN, Bosch I, deBosch NB. Multivariate time-series analysis of biomarkers from a dengue cohort offers new approaches for diagnosis and prognosis. PLoS neglected tropical diseases. 2020 Jun 16;14(6):e0008199.
Herrera BB, Tsai WY, Brites C, Luz E, Pedroso C, Drexler JF, Wang WK, Kanki PJ. T cell responses to nonstructural protein 3 distinguish infections by Dengue and Zika viruses. MBio. 2018 Aug 7;9(4):e00755-18.
Herrera BB, Hamel DJ, Oshun P, Akinsola R, Akanmu AS, Chang CA, Eromon P, Folarin O, Adeyemi KT, Happi CT, Lu Y, Ogunsola S, Kanki PJ. A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals. PLoS neglected tropical diseases. 2018 May 24;12(5):e0006530.
Herrera BB*, Tsai WY*, Chang CA, Hamel DJ, Wang WK, Lu Y, Mboup S, Kanki PJ. Sustained specific and cross-reactive T cell responses to Zika and dengue virus NS3 in West Africa. Journal of virology. 2018 Mar 14;92(7):e01992-17.
Herrera BB, Chang CA, Hamel DJ, Mboup S, Ndiaye D, Imade G, Okpokwu J, Agbaji O, Bei AK, Kanki PJ. Continued transmission of Zika virus in humans in West Africa, 1992–2016. The Journal of infectious diseases. 2017 May 15;215(10):1546-50.
Russo BC, Stamm LM, Raaben M, Kim CM, Kahoud E, Robinson LR, Bose S, Queiroz AL, Herrera BB, Baxt LA, Mor-Vaknin N, Fu Y, Molina G, Markovitz DM, Whelan SP, Goldberg MB. Intermediate filaments enable pathogen docking to trigger type 3 effector translocation. Nature microbiology. 2016 Mar 7;1(4):1-1.
Lu R*, Herrera BB*, Eshleman HD, Fu Y, Bloom A, Li Z, Sacks DB, Goldberg MB. Shigella effector OspB activates mTORC1 in a manner that depends on IQGAP1 and promotes cell proliferation. PLoS pathogens. 2015 Oct 16;11(10):e1005200.
Yi CR, Allen JE, Russo B, Lee SY, Heindl JE, Baxt LA, Herrera BB, Kahoud E, MacBeath G, Goldberg MB. Systematic analysis of bacterial effector-postsynaptic density 95/disc large/zonula occludens-1 (PDZ) domain interactions demonstrates Shigella OspE protein promotes protein kinase C activation via PDLIM proteins. Journal of Biological Chemistry. 2014 Oct 24;289(43):30101-13.